Boston Scientific Income taxes payable – long-term increased by 4.1% to $403.00M in Q3 2025 compared to the prior quarter. Year-over-year, this metric grew by 10.7%, from $364.00M to $403.00M. Over 4 years (FY 2020 to FY 2024), Income taxes payable – long-term shows a downward trend with a -10.1% CAGR.
other_accrued_income_taxes_noncurrent| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $535.00M | $541.00M | $442.00M | $451.00M | $550.00M | $549.00M | $597.00M | $608.00M | $489.00M | $487.00M | $470.00M | $466.00M | $356.00M | $364.00M | $357.00M | $361.00M | $387.00M | $403.00M |
| QoQ Change | — | +1.1% | -18.3% | +2.0% | +22.0% | -0.2% | +8.7% | +1.8% | -19.6% | -0.4% | -3.5% | -0.9% | -23.6% | +2.2% | -1.9% | +1.1% | +7.2% | +4.1% |
| YoY Change | — | — | — | — | +2.8% | +1.5% | +35.1% | +34.8% | -11.1% | -11.3% | -21.3% | -23.4% | -27.2% | -25.3% | -24.0% | -22.5% | +8.7% | +10.7% |